Board of Directors - Smiths Group plc

Donald had a 20-year career with Barclays Group, during which time he was Chairman and Chief Executive of BZW Investment Management and acting Chief Executive of BZW. This was followed by 10 years with the AXA Group where he held the posts of Chairman and Chief Executive of AXA Investment Managers and was Chairman of AXA Framlington. He has recently retired from the Boards of AXA Investment Managers SA and AXA Rosenberg LLP. He was also formerly the chairman of the London Metal Exchange, Taylor Nelson Sofres plc and Amersham plc and a non-executive director of Allied Domecq plc and Scottish Power plc.

• Chairman of the Nomination Committee
• Remuneration Committee

• Chairman of Royal Mail Group plc and Chairman of its Nominations committee
• Chairman of Sage Group plc
• Chairman Designate of the Medical Research Council

Philip was previously Chief Executive of Scottish Power plc and Allied Domecq plc. He also held non-executive directorships at British Sky Broadcasting Group plc, Scottish and Newcastle Group plc and Coles Myer Limited as well as having been Chairman of Liberty plc and Coral Eurobet plc. His earlier career included five years as a director of Bass plc, where he held the roles of Chief Financial Officer and subsequently Chief Executive of Bass Taverns.

• Senior Independent Director and Chairman of the Audit Committee of Burberry Group plc
• Non-executive director of Better Capital PCC Limited
• Chairman of The Miller Group Limited

Peter joined Smiths Group from the independent oil company, Venture Production plc, where he was the Finance Director. He previously held a number of senior finance posts at the global gases group, BOC Group plc, including Director of Taxation and Treasury and Finance Director of the Group’s largest division. Peter has wide knowledge and experience of multi-national operations, including the oil and gas sector.

Bruno’s career includes senior management roles in pharmaceutical and medical device companies. Bruno retired from AstraZeneca in 2009 as Executive Vice President, International after a 20-year career. He was responsible for Europe, Japan, Asia Pacific, Latin America, Middle East and Africa and originally joined as President of ICI Pharma France. Prior to this, he was at Baxter, a USbased global supplier of medical devices. He has extensive international experience, including in the US, and brings a deep understanding to the Group of the medical device and pharmaceutical industries.

• Audit Committee
• Nomination Committee
• Remuneration Committee

• Member of the Global Advisory Board of Takeda Pharmaceutical Company Ltd, Japan
• Non-executive director of Novo Nordisk A/S, a Danish healthcare company
• Member of the Supervisory Board and the Audit Committee of Wolters Kluwer nv, a Dutch-based information services and publishing company

David had a long and distinguished career in investment banking. He is a former Chairman of J Henry Schroder & Co, where he spent most of his professional career. He was the first chairman of the Financial Services Practitioner Panel set up under the act which created the Financial Services Authority. He has an in-depth understanding of capital markets and provides valuable support to the Group on key financial matters.

• Chairman of the Audit Committee
• Nomination Committee
• Remuneration Committee

• Senior Independent Director and Chairman of the Audit Committee of Anglo American plc
• Chairman of the Citigroup EMEA Governance Committee
• Deputy Chairman of the Takeover Panel
• Member of the Financial Reporting Council’s advisory group of audit committee chairmen

Tanya was CEO of Diamond Innovations Inc., a world-leading manufacturer of super-abrasive products for the material removal industry, until 2010. Before that she enjoyed a successful 20-year career with GE. She held a number of senior positions in product management, operations, Six Sigma and supply chain management. Tanya provides Smiths with wide experience in product innovation and sales and marketing in a range of sectors.

• Audit Committee
• Nomination Committee
• Remuneration Committee

• Non-executive director of Boart Longyear Ltd, an Australian-listed, US-based mining products and services company

Anne spent her early career with NZ Forest Products Limited and the US management consulting company, Resource Planning Associates. She has extensive overseas experience in the oil and gas sector, having enjoyed a successful 20-year career with BP. She held a number of executive positions including Group Vice President in the US, Belgium, Colombia and the UK. Following her career with BP, Anne was a director of Riverstone LLP, an energy private equity group. Anne’s experience is a great benefit to the Group in its development of new geographic markets and its exposure to the oil and gas sector.

• Chair of the Remuneration Committee
• Audit Committee
• Nomination Committee

• Senior Independent Director and Chair of the Remuneration Committee of Mondi plc and Mondi Limited, a company dual-listed in the UK and South Africa

Sir Kevin held policy management and finance posts in the MoD, Foreign and Commonwealth Office and NATO. These included three years service in Washington as Defence and European Counsellor at the British Embassy before becoming Director of GCHQ and finally Permanent Under Secretary at the Ministry of Defence from 1998 to 2005. Sir Kevin’s career as a former senior British civil servant provides Smiths with considerable experience in the defence sector and in government relations issues.

• Audit Committee
• Nomination Committee
• Remuneration Committee

• Senior Adviser to URS Corporation
• Senior Associate Fellow at Royal United Services Institute
• Chairman of the Industry Advisory Group to the UKTI Defence and Security Organisation
• Visiting Professor at Queen Mary University, London
• Member of the Advisory Board of the Imperial College Institute for Security and Technology